A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H

Journal of Virology

Volumn 79, Issue 14, 2005, Pages 9254-9269

  Öberg, Daniel ^a   Fay, Joanna ^b   Lambkin, Helen ^b   Schwartz, Stefan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CSTF 64 PROTEIN; HETERONUCLEAR RIBONUCLEOPROTEIN H; MESSENGER RNA; PROTEIN; RIBONUCLEOPROTEIN; RNA; UNCLASSIFIED DRUG;

ARTICLE; GENE EXPRESSION; GENE INDUCTION; GENE MUTATION; GGG MOTIF; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; L1 GENE; L2 GENE; MODEL; NONHUMAN; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STAINING; TISSUE DIFFERENTIATION; TRINUCLEOTIDE REPEAT; UTERINE CERVIX EPITHELIUM; VIRUS GENE; VIRUS PARTICLE;

BASE SEQUENCE; CAPSID PROTEINS; CELL DIFFERENTIATION; CERVIX UTERI; FEMALE; HELA CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP F-H; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; OPEN READING FRAMES; POLYADENYLATION; RNA; RNA SPLICING;

HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 21644476594     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.14.9254-9269.2005     Document Type: Article

References (51)

1. Ahmed, Y. F., G. M. Gilmartin, S. M. Hanly, J. R. Nevins, and W. C. Greene. 1991. The HTLV-I Rex response element mediates a novel form of mRNA polyadenylation. Cell 64:727-737.
2. Arhin, G. K., M. Boots, P. S. Bagga, C. Milcarek, and J. Wilusz. 2002. Downstream sequence elements with different affinities for the hnRNP H/H′ protein influence the processing efficiency of mammalian polyadenylation signals. Nucleic Acids Res. 30:1842-1850.
3. Bagga, P. S., G. K. Arhin, and J. Wilusz. 1998. DSEF-1 is a member of the hnRNP H family of RNA-binding proteins and stimulates pre-mRNA cleavage and polyadenylation in vitro. Nucleic Acids Res. 26:5343-5350.
4. Baker, C. C. 1997. Posttranscriptional regulation of papillomavirus gene expression. In S. R. Billakanti, C. E. Calef, A. D. Farmer, A. L. Halpern, and G. L. Myers (ed.), Human papillomaviruses: a compilation and analysis of nucleic acid and amino acid sequences. Theoretical biology and biophysics. Los Alamos National Laboratory, Los Alamos, N. Mex.
5. Baker, C. C., and J. S. Noe. 1989. Transcriptional termination between bovine papillomavirus type 1 (BPV-1) early and late polyadenylation sites blocks late transcription in BPV-1-transformed cells. J. Virol. 63:3529-3534.
6. Bar-Shira, A., A. Panet, and A. Honigman. 1991. An RNA secondary structure juxtaposes two remote genetic signals for human T-cell leukemia virus type I RNA 3′-end processing. J. Virol. 65:5165-5173.
7. Caputi, M., and A. M. Zahler. 2001. Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H′/F/2H9 family. J. Biol. Chem. 276:43850-43859.
8. Cid-Arregui, A., V. Juarez, and H. zur Hausen. 2003. A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J. Virol. 77:4928-4937.
9. Collier, B., L. Goobar-Larsson, M. Sokolowski, and S. Schwartz. 1998. Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J. Biol. Chem. 273:22648-22656.
10. Collier, B., D. Oberg, X. Zhao, and S. Schwartz. 2002. Specific inactivation of inhibitory sequences in the 5′ end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells. J. Virol. 76:2739-2752.
11. Cumming, S. A., C. E. Repellin, M. McPhillips, J. C. Radford, J. B. Clements, and S. V. Graham. 2002. The human papillomavirus type 31 late 3′ untranslated region contains a complex bipartite negative regulatory element. J. Virol. 76:5993-6003.
12. deVilliers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology 324:17-27.
13. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
14. Disbrow, G. L., I. Sunitha, C. C. Baker, J. Hanover, and R. Schlegel. 2003. Codon optimisation of the HPV-16 E5 gene enhances protein expression. Virology 311:105-114.
15. Fogel, B. L., L. M. McNally, and M. T. McNally. 2002. Efficient polyadenylation of Rous sarcoma virus RNA requires the negative regulator of splicing element. Nucleic Acids Res. 30:810-817.
16. Furth, P. A., and C. C. Baker. 1991. An element in the bovine papillomavirus late 3′ untranslated region reduces polyadenylated cytoplasmic RNA levels. J. Virol. 65:5806-5812.
17. Gilmartin, G. M., E. S. Fleming, and J. Oetjen. 1992. Activation of HIV-1 pre-mRNA 3′ processing in vitro requires both an upstream element and TAR. EMBO J. 11:4419-4428.
18. Hans, H., and J. C. Alwine. 2000. Functionally significant secondary structure of the simian virus 40 late polyadenylation signal. Mol. Cell. Biol. 20:2926-2932.
19. Honore, B., H. H. Rasmussen, H. Vorum, K. Dejgaard, X. Liu, P. Gromov, P. Madsen, B. Gesser, N. Tommerup, and J. E. Celis. 1995. Heterogeneous nuclear ribonucleoproteins H, H′, and F are members of a ubiquitously expressed subfamily of related but distinct proteins encoded by genes mapping to different chromosomes. J. Biol. Chem. 270:28780-28789.
20. Howley, P. M. 1996. Papillomavirinae: the viruses and their replication, p. 2045-2076. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven Publishers. Philadelphia, Pa.
21. Kaufmann, I., G. Martin, A. Friedlein, H. Langen, and W. Keller. 2004. Human Fip1 is a subunit of CPSF that binds to U-rich elements and stimulates poly(A) polymerase. EMBO J. 23:616-626.
22. Kennedy, I. M., J. K. Haddow, and J. B. Clements. 1990. Analysis of human papillomavirus type 16 late mRNA 3′ processing signals in vitro and in vivo. J. Virol. 64:1825-1829.
23. Kennedy, I. M., J. K. Haddow, and J. B. Clements. 1991. A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability. J. Virol. 65:2093-2097.
24. Koffa, M. D., S. V. Graham, Y. Takagaki, J. L. Manley, and J. B. Clements. 2000. The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels. Proc. Natl. Acad. Sci. USA 97:4677-4682.
25. Liu, W. J., F. Gao, K. N. Zhao, G. J. Fernando, R. Thomas, and I. H. Frazer. 2002. Codon modified human papillomvirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumour activity. Virology 301:43-52.
26. Longworth, M. S., and L. A. Laimins. 2004. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol. Mol. Biol. Rev. 68:362-372.
27. Mahe, D., P. Mahl, R. Gattoni, N. Fisher, M. G. Mattei, J. Stevenin, and J. P. Fuchs. 1997. Cloning of human 2H9 heterogeneous nuclear ribonucleoproteins. Relation with splicing and early heat shock-induced splicing arrest. J. Biol. Chem. 272:1827-1836.
28. Matunis, M. J., J. Xing, and G. Dreyfuss. 1994. The hnRNP F protein: unique primary structure, nucleic acid-binding properties, and subcellular localization. Nucleic Acids Res. 22:1059-1067.
29. McPhillips, M. G., T. Veerapraditsin, S. A. Cumming, D. Karali, S. G. Milligan, W. Boner, I. M. Morgan, and S. V. Graham. 2004. SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells. J. Virol. 78:10598-10605.
30. Öberg, D., B. Collier, X. Zhao, and S. Schwartz. 2003. Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells. J. Virol. 77:11674-11684.
31. Phillips, C., C. B. Kyriakopoulou, and A. Virtanen. 1999. Identification of a stem-loop structure important for polyadenylation at the murine IgM secretory poly(A) site. Nucleic Acids Res. 27:429-438.
32. Schwartz, S. 1998. cis-acting negative RNA elements on papillomavirus late mRNAs. Semin. Virol. 8:291-300.
33. Schwartz, S. 2000. Regulation of human papillomavirus late gene expression. Ups. J. Med. Sci. 105:171-192.
34. Schwartz, S., X. Zhao, D. Öberg, and M. Rush. 2004. Regulation of papillomavirus late gene expression. Recent Res. Dev. Virol. 6:29-45.
35. Shah, K. V., and P. M. Howley. 1996. Papillomaviruses, p. 2077-2109. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven Publishers, Philadelphia, Pa.
36. Sokolowski, M., H. Furneaux, and S. Schwartz. 1999. The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3′ untranslated region correlates with its affinity for the elav-like HuR protein. J. Virol. 73:1080-1091.
37. Sokolowski, M., W. Tan, M. Jellne, and S. Schwartz. 1998. mRNA instability elements in the human papillomavirus type 16 L2 coding region. J. Virol. 72:1504-1515.
38. Spångberg, K., L. Wiklund, and S. Schwartz. 2000. HuR, a protein implicated in oncogene and growth factor mRNA decay, binds to the 3′ ends of hepatitis C virus RNA of both polarities. Virology 274:378-390.
39. Takagaki, Y., and J. L. Manley. 1997. RNA recognition by the human polyadenylation factor CstF. Mol. Cell. Biol. 17:3907-3914.
40. Tan, W., B. K. Felber, A. S. Zolotukhin, G. N. Pavlakis, and S. Schwartz. 1995. Efficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1. J. Virol. 69:5607-5620.
41. Tan, W., and S. Schwartz. 1995. The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3′ untranslated region. J. Virol. 69:2932-2945.
42. Terhune, S. S., W. G. Hubert, J. T. Thomas, and L. A. Laimins. 2001. Early polyadenylation signals of human papillomavirus type 31 negatively regulate capsid gene expression. J. Virol. 75:8147-8157.
43. Terhune, S. S., C. Milcarek, and L. A. Laimins. 1999. Regulation of human papillomavirus type 31 polyadenylation during the differentiation-dependent life cycle. J. Virol. 73:7185-7192.
44. Veraldi, K. L., G. K. Arhin, K. Martincic, L. H. Chung-Ganster, J. Wilusz, and C. Milcarek. 2001. hnRNP F influences binding of a 64-kilodalton subunit of cleavage stimulation factor to mRNA precursors in mouse B cells. Mol. Cell. Biol. 21:1228-1238.
45. Wahle, E., and U. Ruegsegger. 1999. 3′-End processing of pre-mRNA in eukaryotes. FEMS Microbiol. Rev. 23:277-295.
46. Wiklund, L., M. Sokolowski, A. Carlsson, M. Rush, and S. Schwartz. 2002. Inhibition of translation by UAUUUAU and UAUUUUUAU motifs of the AU-rich RNA instability element in the HPV-1 late 3′ untranslated region. J. Biol. Chem. 277:40462-40471.
47. Wu, C., and J. C. Alwine. 2004. Secondary structure as a functional feature in the downstream region of mammalian polyadenylation signals. Mol. Cell. Biol. 24:2789-2796.
48. Zhao, X., D. Öberg, M. Rush, and S. Schwartz. 2005. A 57 nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and PTB. J. Virol. 79:4270-4288.
49. Zhao, X., M. Rush, and S. Schwartz. 2004. Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene. J. Virol. 78:10888-10905.
50. zur Hausen, H. 2002. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2:342-350.
51. zur Hausen, H., and E. M. de Villiers. 1994. Human papillomaviruses. Annu. Rev. Microbiol. 48:427-447.